IBDEI2GE ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,41612,1,4,0)
 ;;=4^N41.9
 ;;^UTILITY(U,$J,358.3,41612,2)
 ;;=^5015694
 ;;^UTILITY(U,$J,358.3,41613,0)
 ;;=N70.91^^159^2006^75
 ;;^UTILITY(U,$J,358.3,41613,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41613,1,3,0)
 ;;=3^Salpingitis,Unspec
 ;;^UTILITY(U,$J,358.3,41613,1,4,0)
 ;;=4^N70.91
 ;;^UTILITY(U,$J,358.3,41613,2)
 ;;=^5015806
 ;;^UTILITY(U,$J,358.3,41614,0)
 ;;=N70.93^^159^2006^74
 ;;^UTILITY(U,$J,358.3,41614,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41614,1,3,0)
 ;;=3^Salpingitis & Oophoritis,Unspec
 ;;^UTILITY(U,$J,358.3,41614,1,4,0)
 ;;=4^N70.93
 ;;^UTILITY(U,$J,358.3,41614,2)
 ;;=^5015808
 ;;^UTILITY(U,$J,358.3,41615,0)
 ;;=N70.92^^159^2006^55
 ;;^UTILITY(U,$J,358.3,41615,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41615,1,3,0)
 ;;=3^Oophoritis,Unspec
 ;;^UTILITY(U,$J,358.3,41615,1,4,0)
 ;;=4^N70.92
 ;;^UTILITY(U,$J,358.3,41615,2)
 ;;=^5015807
 ;;^UTILITY(U,$J,358.3,41616,0)
 ;;=N73.9^^159^2006^37
 ;;^UTILITY(U,$J,358.3,41616,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41616,1,3,0)
 ;;=3^Inflammatory Disease Female Pelvic,Unspec
 ;;^UTILITY(U,$J,358.3,41616,1,4,0)
 ;;=4^N73.9
 ;;^UTILITY(U,$J,358.3,41616,2)
 ;;=^5015820
 ;;^UTILITY(U,$J,358.3,41617,0)
 ;;=A56.11^^159^2006^36
 ;;^UTILITY(U,$J,358.3,41617,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41617,1,3,0)
 ;;=3^Inflammatory Disease Chlamydial Female Pelvic
 ;;^UTILITY(U,$J,358.3,41617,1,4,0)
 ;;=4^A56.11
 ;;^UTILITY(U,$J,358.3,41617,2)
 ;;=^5000342
 ;;^UTILITY(U,$J,358.3,41618,0)
 ;;=N73.5^^159^2006^64
 ;;^UTILITY(U,$J,358.3,41618,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41618,1,3,0)
 ;;=3^Peritonitis Female Pelvic,Unspec
 ;;^UTILITY(U,$J,358.3,41618,1,4,0)
 ;;=4^N73.5
 ;;^UTILITY(U,$J,358.3,41618,2)
 ;;=^5015817
 ;;^UTILITY(U,$J,358.3,41619,0)
 ;;=N72.^^159^2006^35
 ;;^UTILITY(U,$J,358.3,41619,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41619,1,3,0)
 ;;=3^Inflammatory Disease Cervix Uteri
 ;;^UTILITY(U,$J,358.3,41619,1,4,0)
 ;;=4^N72.
 ;;^UTILITY(U,$J,358.3,41619,2)
 ;;=^5015812
 ;;^UTILITY(U,$J,358.3,41620,0)
 ;;=N76.3^^159^2006^92
 ;;^UTILITY(U,$J,358.3,41620,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41620,1,3,0)
 ;;=3^Vulvitis,Subacute & Chronic
 ;;^UTILITY(U,$J,358.3,41620,1,4,0)
 ;;=4^N76.3
 ;;^UTILITY(U,$J,358.3,41620,2)
 ;;=^5015829
 ;;^UTILITY(U,$J,358.3,41621,0)
 ;;=N76.1^^159^2006^88
 ;;^UTILITY(U,$J,358.3,41621,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41621,1,3,0)
 ;;=3^Vaginitis,Subacute & Chronic
 ;;^UTILITY(U,$J,358.3,41621,1,4,0)
 ;;=4^N76.1
 ;;^UTILITY(U,$J,358.3,41621,2)
 ;;=^5015827
 ;;^UTILITY(U,$J,358.3,41622,0)
 ;;=N76.2^^159^2006^91
 ;;^UTILITY(U,$J,358.3,41622,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41622,1,3,0)
 ;;=3^Vulvitis,Acute
 ;;^UTILITY(U,$J,358.3,41622,1,4,0)
 ;;=4^N76.2
 ;;^UTILITY(U,$J,358.3,41622,2)
 ;;=^5015828
 ;;^UTILITY(U,$J,358.3,41623,0)
 ;;=N76.0^^159^2006^87
 ;;^UTILITY(U,$J,358.3,41623,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41623,1,3,0)
 ;;=3^Vaginitis,Acute
 ;;^UTILITY(U,$J,358.3,41623,1,4,0)
 ;;=4^N76.0
 ;;^UTILITY(U,$J,358.3,41623,2)
 ;;=^5015826
 ;;^UTILITY(U,$J,358.3,41624,0)
 ;;=M00.20^^159^2006^3
 ;;^UTILITY(U,$J,358.3,41624,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41624,1,3,0)
 ;;=3^Arthritis Streptococcal,Unspec Joint
 ;;^UTILITY(U,$J,358.3,41624,1,4,0)
 ;;=4^M00.20
 ;;^UTILITY(U,$J,358.3,41624,2)
 ;;=^5009645
 ;;^UTILITY(U,$J,358.3,41625,0)
 ;;=M00.80^^159^2006^4
 ;;^UTILITY(U,$J,358.3,41625,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41625,1,3,0)
 ;;=3^Arthritis d/t Bacteria,Unspec Joint
 ;;^UTILITY(U,$J,358.3,41625,1,4,0)
 ;;=4^M00.80
